Cargando…
Metformin Suppresses the Progress of Diabetes-Accelerated Atherosclerosis by Inhibition of Vascular Smooth Muscle Cell Migration Through AMPK–Pdlim5 Pathway
Backgrounds: Our previous work revealed that AMP-activated protein kinase (AMPK) activation inhibits vascular smooth muscle cell migration in vitro by phosphorylating PDZ and LIM domain 5 (Pdlim5). As metformin is an AMPK activator, we used a mouse vascular smooth muscle cell (VSMC) line and a Myh11...
Autores principales: | Yan, Yi, Li, Ting, Li, Zhonghao, He, Mingyuan, Wang, Dejiang, Xu, Yingyi, Yang, Xuewen, Bai, Yuanyuan, Lao, Yi, Zhang, Zhiyong, Wu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342753/ https://www.ncbi.nlm.nih.gov/pubmed/34368251 http://dx.doi.org/10.3389/fcvm.2021.690627 |
Ejemplares similares
-
Augmented AMPK activity inhibits cell migration by phosphorylating the novel substrate Pdlim5
por: Yan, Yi, et al.
Publicado: (2015) -
High expression of PDLIM5 facilitates cell tumorigenesis and migration by maintaining AMPK activation in prostate cancer
por: Liu, Xi, et al.
Publicado: (2017) -
Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity
por: Singh, Manrose, et al.
Publicado: (2022) -
Senescence in Vascular Smooth Muscle Cells and Atherosclerosis
por: Zha, Yiwen, et al.
Publicado: (2022) -
Endothelial–Vascular Smooth Muscle Cells Interactions in Atherosclerosis
por: Li, Manna, et al.
Publicado: (2018)